Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

[1]  G. Kochs,et al.  Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene , 2007, Proceedings of the National Academy of Sciences.

[2]  Anthony S Fauci,et al.  The 1918 influenza pandemic: insights for the 21st century. , 2007, The Journal of infectious diseases.

[3]  J. Rehg,et al.  Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. , 2007, Comparative medicine.

[4]  David E. Swayne,et al.  Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus , 2006, Nature.

[5]  P. Palese,et al.  Influenza A Virus PB1-F2 Protein Contributes to Viral Pathogenesis in Mice , 2006, Journal of Virology.

[6]  J. McCullers.  Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[7]  J. Rehg,et al.  Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets , 2006, Infection and Immunity.

[8]  C. Naeve,et al.  Large-Scale Sequence Analysis of Avian Influenza Isolates , 2006, Science.

[9]  David E. Swayne,et al.  Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.

[10]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[11]  Rong Wang,et al.  Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 , 2005, PLoS pathogens.

[12]  J. McCullers,et al.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia. , 2005, The Journal of infectious diseases.

[13]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[14]  J. McCullers.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. , 2004, The Journal of infectious diseases.

[15]  J. Yewdell,et al.  PB1-F2, an Influenza A Virus-Encoded Proapoptotic Mitochondrial Protein, Creates Variably Sized Pores in Planar Lipid Membranes , 2004, Journal of Virology.

[16]  Jonathan W. Yewdell,et al.  The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function , 2003, Journal of Virology.

[17]  J. McCullers,et al.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.

[18]  M. Lipsitch,et al.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Legge,et al.  Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. , 2003, Immunity.

[20]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[21]  R. Webster,et al.  Eight-plasmid system for rapid generation of influenza virus vaccines. , 2002, Vaccine.

[22]  J. Rehg,et al.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.

[23]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[24]  J. McCullers,et al.  Molecular pathogenesis of pneumococcal pneumonia. , 2001, Frontiers in bioscience : a journal and virtual library.

[25]  Marc Lipsitch,et al.  Visualizing Pneumococcal Infections in the Lungs of Live Mice Using Bioluminescent Streptococcus pneumoniaeTransformed with a Novel Gram-Positive luxTransposon , 2001, Infection and Immunity.

[26]  L. Simonsen,et al.  The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.

[27]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[28]  L. Simonsen.  The global impact of influenza on morbidity and mortality. , 1999, Vaccine.

[29]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[30]  H. Goto,et al.  Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.

[31]  H. Wallenburg,et al.  LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAE , 1986, The Lancet.

[32]  C. Stuart-harris,et al.  Influenza and its complications. , 1959, British medical bulletin.

[33]  C. Stuart-harris,et al.  VIRUS AND RICKETTSIAL DISEASES , 1951 .

[34]  Gordon C. Brown.  VIRUS and rickettsial diseases. , 1956, Research program. United States. Army. Medical Department.

[35]  A. Abrahams,et al.  A further Investigation INTO INFLUENZO-PNEUMOCOCCAL AND INFLUENZO-STREPTOCOCCAL SEPTICÆMIA: EPIDEMIC INFLUENZAL "PNEUMONIA" OF HIGHLY FATAL TYPE AND ITS RELATION TO "PURULENT BRONCHITIS." , 1919 .

[36]  G. Swift,et al.  INFLUENZA AND INFLUENZAL PNEUMONIA AT FORT RILEY, KANSAS: FROM SEPT. 15 TO NOV. 1, 1918 , 1919 .

[37]  R. Muir,et al.  Observations ON INFLUENZA AND ITS COMPLICATIONS , 1919, British medical journal.